Income investing

Village door

The Village Door® Seascape: Buy a Prime Piece of Florida’s Lucrative Tourism Industry

The restaurant and nightclub industry has been steadily growing over the years, providing owners with reliable cash flow and equity appreciation. Florida has become an especially appealing opportunity for these venues given its pristine white sand beaches and year-round tourism-driven economy. Accredited investors looking for an opportunity to participate in this growth may want to consider the Village Door® Seascape.

Air Products (APD): A Reliable Dividend & an Interesting Spin-Off

Why Gold Miners Are the Best Bet for Income Investors

Don't Let These Muni Tax Traps Hurt Your Portfolio

Top 3 Dividend Stocks to Buy Following the Brexit

Wells Fargo (WFC): Income Investing Alongside Warren Buffett

Value investing

Depositphotos 87558978 s 2015

Black Iron CEO Outlines Turnaround Potential in Exclusive Interview

Some of the best investment opportunities are turnaround plays that arise when uncontrollable factors precipitate a company’s decline. When those issues are resolved, it often takes the market a long time to realize the opportunity, which provides a window for value investors.

Black Iron: A Low Cost High Grade Turnaround Iron Ore Play

Where to Invest in the Growing Travel Industry

Filling in the Alternative Lodging Industry’s Missing Piece

What the Lassonde Curve Says About Golden Arrow

Golden Arrow Finalizes Deal with Silver Standard

Biotech focus


AXIM Biotech Advances Programs Through Traditional Biotech Pathways, Positive Meeting with FDA

AXIM® Biotech is advancing cannabinoid-based treatments for conditions ranging from IBS to cancer and AIDS support. The company recently got the green light from the FDA to file an IND for its functional, controlled-release chewing gum to support weight and appetite loss stemming from chemotherapy and AIDS.

AXIM Targets Cannabinoid-based Ophthalmic Solutions

How Cannabis Could Solve the Opioid Crisis

Zynerba Failure Highlights the Need for Expertise, Broader Portfolios

Diabetes: Silence the Messenger, Don’t Shoot It!

AXIM Biotech: Cannabinoid Potential Worth the Complexity